AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2025

Aug 13, 2025

32870_dirs_2025-08-13_4225817e-2644-40ea-b935-71b717cd0892.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2025-08-12

Reporting Person: DeGolyer Donald W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-12	Common Stock	S	7844	$8.6475	Disposed	137659	Direct

Footnotes

F1: Represents the number of shares sold by the Reporting Person to satisfy the Reporting Person's tax obligations resulting from the settlement of vested RSUs on May 22, 2025.

F2: All shares sold at an exact price of $8.6475.